Form 4: Teladoc Director Catherine Jacobson Equity Update

Director Catherine Jacobson acquired 28,986 shares via RSU vesting and was granted 30,441 new restricted stock units.

Summary

• Director Catherine Jacobson exercised 28,986 restricted stock units (RSUs) which vested on May 20, 2026.
• Following the transaction, Jacobson holds 66,853 shares of Teladoc Health common stock.
• On May 21, 2026, Jacobson was granted an additional 30,441 RSUs.
• The new RSU grant is scheduled to vest on the earlier of May 21, 2027, or the day before the 2027 annual meeting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding director compensation and equity ownership.

Positives

• Director maintains a significant equity stake of 66,853 shares, aligning interests with shareholders.

Negatives

• None identified; this is a standard equity compensation disclosure.

Risks

• Future value of equity grants is subject to market performance of TDOC common stock.

Future Outlook

The director holds 30,441 unvested restricted stock units expected to vest in May 2027.

Industry Context

StockSavvy.ai notes that routine equity compensation disclosures for directors are standard practice in the telehealth sector and do not typically signal changes in corporate strategy or financial health.

Comparison to Industry Standards

• The equity compensation structure is consistent with standard corporate governance practices for publicly traded healthcare technology companies.

Stakeholder Impact

• No material impact on shareholders, employees, or creditors as this is a standard compensation event.

Next Steps

• Vesting of 30,441 restricted stock units on or before May 21, 2027.

Key Dates

Keywords

Teladoc Health, TDOC, Insider Trading, Form 4, Equity Compensation, Director Ownership